Narine Baririan, Pharm. D


Early Phase Clinical Trials in Patients With Hepatic or Renal Impairment

August 26, 2016

Studies in Hepatic and Renal Impaired special populations have almost always required drugs with systematic absorption resulting in unclear conclusions. A solution for this would be a study design based on pharmokinetic properties that incorporates principles of Hepatic and Renal Impaired pathologies.